Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2β- carbomethoxy-3β-(4'-methylphenyl)nortropane as a selective and potent inhibitor of the neuronal dopamine transporter

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 2, 1999, Pages 648-654

  Chalon, Sylvie ^a   Garreau, Lucette ^a   Emond, Patrick ^a   Zimmer, Luc ^a   Vilar, Marie Paule ^a   Besnard, Jean Claude ^a   Guilloteau, Denis ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE DERIVATIVE; DOPAMINE TRANSPORTER; N (3 IODOPROP 2 ENYL) 2BETA CARBOMETHOXY 3BETA (4' METHYLPHENYL)NORTROPANE; NORTROPANE DERIVATIVE; UNCLASSIFIED DRUG; VANOXERINE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; DOPAMINE UPTAKE; DRUG BINDING SITE; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032696608     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Amara SG and Kuhar MJ (1993) Neurotransmitter transporters. Annu Rev Neurosci 16:73-93.
2. + dependence of the neuronal transport of dopamine. J Neurochem 59:1795-1804.
3. 125I]iodophenyl)tropane-2β-carboxylic acid isopropyl ester. Mol Pharmacol 47:779-786.
4. Boja JW, Carroll FI, Rahman MA, Philip A, Lewin AH and Kuhar MJ (1990) New, potent cocaine analogs: Ligand binding and transport studies in rat striatum. Eur J Pharmacol 184:329-332.
5. 125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex. Synapse 30:9-17.
6. Boja JW, McNeill RM, Lewin AH, Abraham P, Carroll FI and Kuhar MJ (1992b) Selective dopamine transporter inhibition by cocaine analogs. NeuroReport 3:984-986.
7. 125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12:27-36.
8. 125I]RTI-55: A potent ligand for dopamine transporters. Eur J Pharmacol 194:133-134.
9. 3H]GBR 12783 to a site associated with the dopamine uptake carrier. J Neurochem 50:759-765.
10. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
11. 123I]β-CIT: Binding kinetics in the human brain. J Neural Transm 94:137-146.
12. Chalon S, Emond P, Bodard S, Vilar MP, Thiercelin C, Besnard JC and Guilloteau D (1999) Time course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markers in a rat model of Parkinson's disease. Synapse 31:134-139.
13. i) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
14. Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, Hersch SM, Niznick HB and Levey AI (1995) The dopamine transporter: Immunochemical characterization and localization in brain. J Neurosci 15:1714-1723.
15. 125I]RTI-55. Brain Res 690:217-224.
16. Emond P, Garreau L, Chalon S, Boazi M, Caillet M, Bricard J, Frangin Y, Mauclaire L, Besnard J-C and Guilloteau D (1997) Synthesis and ligand binding of nortropane derivatives: N-Substituted 2β-carbomethoxy-3β-(4′-iodophenyl) nortropane and N-(3-iodoprop-2E-enyl)-2β-carbomethoxy-3β-(3′,4′- disubstituted phenyl)nortropane: New high-affinity and selective compounds for the dopamine transporter. J Med Chem 40:1366-1372.
17. 11C]β-CIT binding to monoamine transporters in the monkey and human brain. Synapse 16:93-103.
18. 125I]RTI-55. J Chem Neuroanat 7:13-23.
19. Gainetdinov RR, Fumagalli F, Jones SR and Caron MG (1997) Dopamine transporter is required for in vivo MPTP neurotoxicity: Evidence from mice lacking the transporter. J Neurochem 69:1322-1325.
20. Garreau L, Emond P, Chalon S, Belzung C, Guilloteau D, Frangin Y, Besnard JC and Guilloteau D (1997) N-(3-iodoprop-2E-enyl)-2β-Carbomethoxy-3β-(3′,4′- dichlorophenyl) nortropane (β-CDIT), a tropane derivative: Pharmacological characterization as a specific ligand for the dopamine transporter in the rodent brain. J Pharmacol Exp Ther 282:467-474.
21. Giros B, El Mestikawy S, Bertrand L and Caron MG (1991) Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett 295:149-154.
22. Giros B, Jaber M, Jones SR, Wightman RM and Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature (Lond) 379:606-612.
23. Goodman MM, Kong MP, Kabalka GW, Kung HF and Switzer R (1994) Synthesis and characterization of radioiodinated N-(3-iodopropen-1-yl)-2β-carbomethoxy-3β-(4-chlorophenyl)tropanes: Potential dopamine reuptake site imaging agents. J Med Chem 37:1535-1542.
24. Guilloteau D, Emond P, Baulieu JL, Garreau L, Frangin Y, Pourcelot L, Mauclaire L, Besnard J-C and Chalon S (1998) Exploration of the dopamine transporter: In vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl) nortropane (PE2I). Nucl Med Biol 25:331-337.
25. 125I]PE2I. Neuroimage 9:108-116.
26. 3H]GBR-12935 binding in brain: A radioligand for selective labelling of the dopamine transport complex. J Neurochem 46:1272-1276.
27. Kirifides AL, Harvey JA and Aloyo VJ (1992) The low affinity binding sites for the cocaine analog, WIN 35,428, is an artifact of freezing caudate tissue. Life Sci 50:139-142.
28. Kuikka JT, Baulieu JL, Hiltunen J, Halldin C, Bergström KA, Farde L, Emond P, Chalon S, Yu M, Nikula T, Laitinen T, Karhu J, Tupala E, Hallikainen T, Kolehmainen V, Mauclaire L, Mazière B, Tiihonen J and Guilloteau D (1998) Pharmacokinetics and dosimetry of iodine-123 labelled PE2I in humans, a radioligand for dopamine transporter imaging. Eur J Nucl Med 25:531-534.
29. Kung MP, Essman WD, Frederick D, Meegala S, Goodman M, Mu M, Lucki I and Kung HF (1995) IPT: A novel iodinated ligand for the CNS dopamine transporter. Synapse 20:316-324.
30. 125I]iodophenyl tropane-2β-carboxylate in vitro binding to dopamine and serotonin transporters under "physiological" conditions. J Neurochem 62:978-986.
31. 123I]β-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab 14:982-994.
32. 3H]Cocaine binding sites in caudate-putamen. J Pharmacol Exp Ther 251:131-141.
33. Madras BK, Meltzer PC, Liang AY, Elmaleh DR, Babich J and Fishman AJ (1998) Altropane, a SPECT or PET imaging probe for dopamine neurons: I. Dopamine transporter binding in primate brain. Synapse 29:93-104.
34. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
35. 3H]GBR 12,935 binding. Mol Pharmacol 45:125-135.
36. 3H]WIN 35,065-2: A ligand for cocaine receptors in striatum. J Neurochem 55:1556-1562.
37. Ritz MC, Cone EJ and Kuhar MJ (1990a) Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: A structure activity study. Life Sci 46:635-645.
38. 125I]RTI-55. J Pharmacol Exp Ther 270:296-309.
39. Uhl GR, Walther D, Mash D, Faucheux B and Javoy-Agid F (1994) Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons. Ann Neurol 35:494-498.
40. 125I]iodophenyl)tropane binding. Mol Pharmacol 43:264-270.